Article

A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness

2021-10-07

Abstract excerpt

<h4>Importance</h4> Little is known about COVID vaccine breakthrough infections and their risk factors. <h4>Objective</h4> To identify risk factors associated with COVID-19 breakthrough infections among vaccinated individuals and to reassess the effectiveness of COVID-19 vaccination against severe outcomes using real-world data. <h4>Design, Setting, and Participants</h4> We conducted a series of observational retr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6bdc29d2-3b8f-560f-b2cf-9bd251d32098
DOI: 10.1101/2021.10.05.21264583

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine EffectivenessDOI 10.1101/2021.10.05.21264583Read

Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort studySemantic proximity Read

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Semantic proximity Read

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELYSemantic proximity Read

COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectivenessSemantic proximity Read

SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccinationSemantic proximity Read

Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.Semantic proximity Read

Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity Read

COVID-19 Vaccine Breakthrough Infections in Veterans Health AdministrationSemantic proximity Read

Durability of protection post-primary COVID-19 vaccination in the US: matched case-control studySemantic proximity Read

Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity Read

Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity Read

Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbiditiesSemantic proximity Read